Tech giants are increasingly stepping up efforts in the science industry. After Google formed a company last year that focuses on tackling aging and other associated diseases, Sony upped its commitment to breakthrough medicine by announcing a joint venture focused on advancing medical research using genetics in Japan. Now Japanese gaming giant DeNA has announced the formation of DeNA Life Science, a wholly-owned subsidiary focused on healthcare services. It will premiere a project known as Mycode, a genetic testing service available first for consumers in Japan. The service is scheduled to launch in late July. More details including pricing will be revealed “soon,” the company says….
This story continues at The Next Web